IL-17 activates MDCs and monocytes to release inflammatory cytokines and recruit neutrophils to the site of infection (Buschow and Jansen, 2021); the lower the methylation of the IL-17 promoter, the more severe the patient’s condition (Tian et al., 2019; Zhu et al., 2022). Here, IL17A is linked to infection.